Precision medicine in aggressive thyroid cancer: Moving beyond multitargeted tyrosine kinase inhibitors

Umair Mahmood; Jochen H. Lorch

doi:10.1002/cncy.22516

Precision medicine in aggressive thyroid cancer: Moving beyond multitargeted tyrosine kinase inhibitors

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	8-11
Number of pages	4
Journal	Cancer Cytopathology
Volume	130
Issue number	1
DOIs	https://doi.org/10.1002/cncy.22516
State	Published - Jan 2022
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncy.22516

Cite this

@article{9f0b94555bf4414f809fabbddb479ede,

title = "Precision medicine in aggressive thyroid cancer: Moving beyond multitargeted tyrosine kinase inhibitors",

author = "Umair Mahmood and Lorch, {Jochen H.}",

note = "Funding Information: Jochen H. Lorch reports institutional research support from Novartis, Bayer, Takeda, and BMS and consulting fees from Bayer and Lilly. The other author made no disclosures.",

year = "2022",

month = jan,

doi = "10.1002/cncy.22516",

language = "English (US)",

volume = "130",

pages = "8--11",

journal = "Cancer Cytopathology",

issn = "1934-662X",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Precision medicine in aggressive thyroid cancer

T2 - Moving beyond multitargeted tyrosine kinase inhibitors

AU - Mahmood, Umair

AU - Lorch, Jochen H.

N1 - Funding Information: Jochen H. Lorch reports institutional research support from Novartis, Bayer, Takeda, and BMS and consulting fees from Bayer and Lilly. The other author made no disclosures.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85118887414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118887414&partnerID=8YFLogxK

U2 - 10.1002/cncy.22516

DO - 10.1002/cncy.22516

M3 - Article

C2 - 34748686

AN - SCOPUS:85118887414

SN - 1934-662X

VL - 130

SP - 8

EP - 11

JO - Cancer Cytopathology

JF - Cancer Cytopathology

IS - 1

ER -

Precision medicine in aggressive thyroid cancer: Moving beyond multitargeted tyrosine kinase inhibitors

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this